Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews

Lignende værker

• QSAR Studies on Neuraminidase Inhibitors as Anti-influenza Agents
  af: VEERASAMY, Ravichandran, et al.
  Udgivet: (2021)
• Assessing taxane-associated adverse events using the FDA adverse event reporting system database
  af: Lao, Dong-Hui, et al.
  Udgivet: (2021)
• Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities
  af: Smee, Donald F., et al.
  Udgivet: (2001)
• Prescription of neuraminidase inhibitors for influenza
  af: Madeley, Dick
  Udgivet: (2003)
• Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system
  af: Han, Lichy, et al.
  Udgivet: (2017)